Background {#Sec1}
==========

*Klebsiella pneumoniae* is a Gram-negative opportunistic pathogen from the family *Enterobacteriaceae*. The increasing resistance detected in clinical isolates has become a matter of significant concern, and *K. pneumoniae* is an ESKAPE (*Enterococcus faecium*, *Staphylococcus aureus*, *K. pneumoniae*, *Acinetobacter baumannii*, *Pseudomonas aeruginosa*, and *Enterobacter* species) pathogen \[[@CR1],[@CR2]\]. Infections caused by *K. pneumoniae* have been identified worldwide. It is worth noting that it is a major cause of nosocomial and community-acquired infections \[[@CR3],[@CR4]\]. Moreover, a distinct invasive syndrome that causes liver abscesses has been detected in increasing numbers in Asia in the past two decades, and this syndrome is emerging as a global disease \[[@CR5],[@CR6]\]. Furthermore, *K. pneumoniae* harboring extended-spectrum β-lactamases, and more recently, carbapenemase, which confers resistance to multiple antibiotics, has become a significant clinical concern worldwide \[[@CR7],[@CR8]\]. Mortality among patients infected with extremely resistant *K. pneumoniae* is high, perhaps due to the limited therapeutic options remaining \[[@CR9]\].

Tigecycline, a novel class of glycylcyclines, is a minocycline derivative synthesized to overcome the major tetracycline resistance mechanisms and to extend its spectrum of activity to multidrug-resistant (MDR) bacteria \[[@CR10]\]. Tigecycline has enhanced antimicrobial activity compared to tetracycline, and can overcome efflux pump systems and ribosome protection mechanisms, retaining activity against a broad range of both Gram-positive and Gram-negative bacteria \[[@CR11]-[@CR13]\]. *K. pneumoniae* resistance to most antibiotics is increasing globally. Nevertheless, tigecycline remains active against many bacterial strains, and serves as last resort for treating MDR bacterial infections \[[@CR14]\]. However, tigecycline resistance has emerged recently and been widely reported in *Enterobacteriaceae* isolates. It is worth noting that tigecycline non-susceptibility among *K. pneumoniae* isolates has been reported from different continents and ranges between 0% and 50% \[[@CR15]-[@CR17]\].

Previous studies have suggested that tigecycline resistance in *Enterobacteriaceae* is attributed to resistance-nodulation-cell division (RND)-type efflux pumps and transcriptional regulators of the efflux pump systems \[[@CR15]\]. However, reports on the tigecycline resistance mechanisms in *K. pneumoniae* are rare. We hypothesized that a wide range of genes is involved in tigecycline resistance and contribute to decreased tigecycline susceptibility in *K. pneumoniae*, and performed whole-genome sequencing (WGS) to investigate this. We report the genome sequence of the tigecycline-resistant *K. pneumoniae* strain 5422 isolated from the bile samples of a patient with cholangiocarcinoma.

Methods {#Sec2}
=======

Strain information and growth conditions {#Sec3}
----------------------------------------

Previously, we isolated strain 5422 from a bile sample obtained from a 54-year-old woman with bile duct cancer on February 25, 2012. After enrichment in Mueller-Hinton broth, the strain was identified as *K. pneumoniae* following the combination of its 16S rRNA gene sequencing and biochemical reaction results (VITEK 2 compact, bioMérieux, France). The strain exhibited high resistance to ciprofloxacin, cefotaxime, cefoxitin, ampicillin/sulbactam, sulfamethoxazole, tigecycline, tetracycline, and piperacillin, and was susceptible to imipenem, meropenem, and gentamicin. Multi-locus sequence typing revealed that it belonged to ST37 (unpublished data). The strain we reported here is available in the State Key Laboratory for Diagonosis and Treatment of Infectious Diseases, Zhejiang University.

Genomic DNA extraction {#Sec4}
----------------------

Late log-phase cells were harvested and lysed with EDTA, lysozyme, and detergent treatment, followed by proteinase K and RNase digestion. Genomic DNA was extracted using a DNeasy Blood & Tissue Kit (Qiagen, Germany) according to the manufacturer's recommended protocol. Genomic DNA yield, purity, and concentration was evaluated using 0.7% agarose gel electrophoresis with λ-*Hin*d III digest DNA Marker and measured using a NanoDrop 1000 Spectrophotometer (Thermo Fisher Scientific, USA). The genomic DNA was stored at-20°C.

Genome sequencing and annotation {#Sec5}
--------------------------------

Whole-genome shotgun sequencing of *K. pneumoniae* strain 5422 was performed using a standard run of IlluminaHiSeq2000 sequencing by generating paired-end libraries (500-bp insert size) with a 2 × 100 pair-end sequencing strategy according to the manufacturer's instructions. Clean reads were assembled into scaffolds using Velvet version 1.2.07 \[[@CR18]\], and then we used PAGIT (Post-Assembly Genome Improvement Toolkit) \[[@CR19]\] to extend the initial contiguous sequences (contigs) and correct sequencing errors. We identified tRNAs and rRNAs using tRNAscan-SE \[[@CR20]\] and RNAmmer \[[@CR21]\], respectively. Open reading frames (ORFs) were identified using Glimmer version 3.0 \[[@CR22]\]. The genome was annotated using the RAST (Rapid Annotation using Subsystem Technology) server \[[@CR23]\]. The classification of some predicted genes and pathways was analyzed using the COGs (Clusters of Orthologous Groups of proteins) \[[@CR24]\] and KEGG (Kyoto Encyclopedia of Genes and Genomes) \[[@CR25]\] databases. Stretches of amino acids containing the efflux pump genes were searched using BLAST (Basic Local Alignment Search Tool, <http://blast.ncbi.nlm.nih.gov/Blast.cgi>); protein-coding sequences were further BLAST-searched against the Antibiotic Resistance Database (ARDB) \[[@CR26]\]. To find genes with hypothetical or putative functions, we aligned genes against the National Center for Biotechnology Information (NCBI) nucleotide sequence database (downloaded September 20, 2013) using NCBI BLASTn: we accepted only hits with identity of ≥ 0.95, coverage ≥ 0.9, and putative or hypothetical reference gene annotation.

Initial comparative genomic and phylogenetic analysis {#Sec6}
-----------------------------------------------------

For comparative analysis, we downloaded the reference genome sequences of the closest genetic relatives of *K. pneumoniae* strain 5422 and representative strains from the NCBI website: *K. pneumoniae* LCT-KP182 (ATRN00000000), *K. pneumoniae* LCT-KP289 (ATRO00000000), *K. pneumoniae* subsp. *pneumoniae* LZ (AJVY00000000), *K. pneumoniae* ATCC BAA-2146 (AOCV00000000), *K. pneumoniae* 12 3578 (PRJNA199972), *K. pneumoniae* NB60 (AZAP00000000), *K. pneumoniae* subsp. *pneumoniae* 1084 (CP003785), *K. pneumoniae* subsp. *pneumoniae* NTUH-K2044 (AP006725), *K. pneumoniae* subsp. *pneumoniae* WGLW5 (AMLO00000000), *K. pneumoniae* ATCC 25955 (AQQH00000000), and *K. pneumoniae* G5-2 (AQQI00000000). Whole-genome alignments, single-nucleotide polymorphism (SNP) identification, and phylogenetic tree construction were performed using snpTree version 1.1, a server for online automatic SNP analysis of assembled genomes (<http://cge.cbs.dtu.dk/services/snpTree-1.1/>) \[[@CR27]\].

Quality assurance {#Sec7}
=================

The 16S rDNA gene from the draft genome was used to check for contamination. Further VITEK biochemical identification data confirmed that the strain 5422 belonged to *K. pneumoniae*. Bioinformatics assessment of potential contamination of the genomic library by allochthonous microorganisms was achieved using the BLAST non-redundant database.

Initial findings {#Sec8}
================

Genome characteristics and phylogenetic analysis {#Sec9}
------------------------------------------------

Filtered 520.8 M clean reads were assembled into scaffolds, and corresponding 99-fold coverage of the genome was generated. The draft genome sequence of *K. pneumoniae* strain 5422 was 5,432,440 bp in size and had a G + C content of 57.1% in 133 contigs, with N50 spanning 105,586 bp. Figure [1](#Fig1){ref-type="fig"}A depicts the overall genome profile. Annotation of this assembly identified 5,397 coding sequences (CDSs), 65 tRNAs (excluding 0 pseudo tRNAs), and incomplete rRNA operons (three small subunit rRNAs, four large subunit rRNAs). We assigned putative function or hypothetical proteins to 1,478 protein-coding genes. We categorized 4,218 genes into COGs functional groups (including putative or hypothetical genes, Figure [1](#Fig1){ref-type="fig"}B). For COGs distribution, R (general function prediction only; 874 ORFs), E (amino acid transport and metabolism; 747 ORFs), G (carbohydrate metabolism and transport; 679 ORFs), and P (inorganic ion transport and metabolism; 525 ORFs) were abundant categories (\>10% of total COGs matched counts).Figure 1**Genome map and phylogenetic analysis. A**. Circular map of the genome generated using Circos. Circles from outside to inside: 1, contigs were arrange in clockwise direction from large to small; 2, CDS on forward strand; 3, CDS on reverse strand; 4, tRNA genes; 5, rRNA genes; 6, GC-skew (window size of 10 kb); and 7, blue indicates C content and yellow indicates G content (step size 500 bp). **B**. COGs distribution of *K. pneumoniae* strain 5422.

Figure [2](#Fig2){ref-type="fig"}A illustrates the subsystem distribution and general information on the potential functional distribution of *K. pneumoniae* strain 5422. Genes responsible for carbohydrates (825 ORFs); amino acids and derivatives (520 ORFs); and cofactors, vitamins, prosthetic groups, and pigments (325 ORFs) were abundant among the SEED subsystem categories. Based on the raw reads and assembled genomes from published *K. pneumoniae* WGS data sets, we conducted phylogenetic analysis on tree topology and the SNP positions of the reference genome to identify the most closely related organism. The phylogenetic tree based on whole-genome SNPs showed that the closest ancestor to *K. pneumoniae* strain 5422 was *K. pneumoniae* ATCC BAA-2146 (Figure [2](#Fig2){ref-type="fig"}B), which is the first US isolate found to encode New Delhi metallo-β-lactamase 1 (NDM-1), eight β-lactamases, and 15 additional antibiotic-resistance enzymes \[[@CR28],[@CR29]\].Figure 2**Subsystem distribution and phylogenetic analysis. A**. Distribution of genes assigned to SEED subsystems (based on the RAST annotation server). **B**. Phylogenetic relationships (based on WGS and SNPs) of 12 *K. pneumoniae* strains and their genomic distance analysis. The snpTree server output used assembled genomes as input data.

RND efflux pumps in K. pneumoniae strain 5422 {#Sec10}
---------------------------------------------

The RND family members are important mediators of MDR in Gram-negative bacteria. The AcrAB-TolC system in *Escherichia coli* and the MexAB-OprM complexes in *P. aeruginosa* are extremely well characterized, and the three-dimensional structures of various components have been resolved \[[@CR30]\]. In the genome of *K. pneumoniae* strain 5422, 16 genes were indicated as probable efflux pumps or translational regulators based on their sequence similarity to known RND efflux pump genes (Table [1](#Tab1){ref-type="table"}).Table 1**Summary of CDSs annotated to RND efflux pump genesAligned proteinQuery sequence lengthCoverage (%)Hit lengthIdentity (%)Description**AcrA24064.1714660.08Probable RND efflux membrane fusion proteinOqxB21720.6614164.98Probable RND efflux system inner membrane transporter CmeBOqxB18118.5311060.77Probable RND multi-drug efflux transporterOqxB16015.2710565.62Probable RND efflux system inner membrane transporter CmeBAcrA397100397100Membrane fusion protein of RND family multi-drug efflux pumpOqxR48310048099.38Transcriptional regulatorOqxB10501001050100RND multi-drug efflux transporterOqxA391100391100RND multi-drug efflux transporterRarA36910036699.19Bacterial regulatory helix-turn-helix proteins, AraC familyOqxB16115.3310162.73Probable RND multi-drug efflux transporterAcrA32883.8924875.61Probable RND efflux system membrane fusion protein CmeAOqxB21720.6714365.9Probable RND efflux system inner membrane transporter CmeBTolC1520100147496.97Outer membrane efflux proteinOqxB32631.0520061.35Probable RND efflux system inner membrane transporter CmeB

Future directions {#Sec11}
=================

The rapid progress of WGS has permitted detailed investigation of genetic differences between bacterial isolates with different phenotypic characteristics. Whole-genome studies of *K. pneumoniae* have mainly focused on comparing either distinct antibiotic-susceptible and MDR strains or related isolates from different patients. Therefore, large-scale genomic sequencing and comparative genome analysis of tigecycline-resistant*,* tigecycline non-susceptible, and tigecycline-susceptible clinical isolates will identify the differences in the genomic content of this species and yield evolutionary information on the development of tigecycline resistance through mutations. Moreover, further studies involving extensive high-throughput mRNA sequencing (RNA-Seq) experiments to significantly improve annotation and to provide exceptionally robust analysis of RNA expression under selective antibiotic pressure are warranted.
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Availability of supporting data {#Sec13}
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This Whole Genome Shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession JGYH00000000. The version described in this paper is version JGYH01000000.
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